Ginsberg R J
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Oncology (Williston Park). 1998 Jan;12(1 Suppl 2):51-4.
The 1997 revision of the lung cancer staging system has added very little to disease staging, and many changes have been totally unnecessary. Before the next revision of the staging system, anticipated in the year 2007, a worldwide effort to collect accurate data bases and analyze a variety of T, N, and M prognostic factors as well as the newer biologic factors is required to define more accurately the clinical and pathologic stages of lung cancer according to prognosis. This approach would allow a more rational consideration of changes in TNM staging. As well, a single, universally accepted lymph node map is needed desperately to unify staging concepts worldwide.
1997年肺癌分期系统的修订在疾病分期方面进展甚微，许多改变完全没有必要。预计2007年进行分期系统的下一次修订，在此之前，需要全球共同努力收集准确的数据库，并分析各种T、N和M预后因素以及更新的生物学因素，以便根据预后更准确地界定肺癌的临床和病理分期。这种方法将使人们能够更合理地考虑TNM分期的变化。此外，迫切需要一个全球通用的淋巴结图谱，以统一全球的分期概念。
